Detailed Mechanism Funding and Narrative

Years of mechanism: 2015 2016 2017 2018

Details for Mechanism ID: 17824
Country/Region: Ethiopia
Year: 2017
Main Partner: Abt Associates
Main Partner Program: NA
Organizational Type: Private Contractor
Funding Agency: USAID
Total Funding: $3,659,773 Additional Pipeline Funding: N/A

NOTE: PEPFAR no longer creates activity narratives for each mechanism. In their place, PEPFAR has begun releasing mechanism specific targets that reveal the achievements and programs that are expected of the funding. If available for this mechanism, these targets are presented below.

Mechanism Allocation by Budget Code for Selected Year
Care: Adult Care and Support (HBHC) $215,587
Care: TB/HIV (HVTB) $132,976
Care: Pediatric Care and Support (PDCS) $120,551
Laboratory Infrastructure (HLAB) $65,289
Health Systems Strengthening (OHSS) $357,620
Testing: HIV Testing and Counseling (HVCT) $692,546
Sexual Prevention: Other Sexual Prevention (HVOP) $134,896
Biomedical Prevention: Prevention of Mother to Child Transmission (MTCT) $264,109
Treatment: Adult Treatment (HTXS) $1,464,839
Treatment: Pediatric Treatment (PDTX) $211,360
Mechanism Target Information

Since COP2014, PEPFAR no longer produces narratives for every mechanism it funds. However, PEPFAR has now included performance targets or indicator information for each mechanism based on the Monitoring, Evaluation, and Reporting (MER) system. The MER guidance is available on PEPFAR's website https://www.pepfar.gov/reports/guidance/. Note that COP years 2014-2015 were under a previous version of the MER system and the indicators and definitions may have changed as of the new 2.0 guidance.

MER Indicator MER description Target Fiscal Year Target
HTS_TST Number of individuals who received T&C services for HIV and received their test results during the past 12 months 2018 319,278
HTS_TST Service Delivery Point Agg Age (Facility) ANC: 15+, Negative 2018 23,166
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Negative 2018 4,474
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Negative 2018 2,541
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Negative 2018 106,152
HTS_TST Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Negative 2018 60,175
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Female, Negative 2018 30
HTS_TST Service Delivery Point Agg Age (Facility) TB: <15, Male, Negative 2018 25
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Female, Negative 2018 1,435
HTS_TST Service Delivery Point Agg Age (Facility) TB: 15+, Male, Negative 2018 986
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Negative 2018 71,222
HTS_TST Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Negative 2018 40,374
HTS_TST Sum of Test Result disaggregates 2018 8,698
HTS_TST_POS By Test Result: Positive 2018 8,698
HTS_TST_POS Service Delivery Point Agg Age (Facility) ANC: 15+, Positive 2018 114
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Female, Positive 2018 79
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: <15, Male, Positive 2018 49
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Female, Positive 2018 3,632
HTS_TST_POS Service Delivery Point Agg Age (Facility) Other PITC: 15+, Male, Positive 2018 2,063
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Female, Positive 2018 4
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: <15, Male, Positive 2018 3
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Female, Positive 2018 249
HTS_TST_POS Service Delivery Point Agg Age (Facility) TB: 15+, Male, Positive 2018 179
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Female, Positive 2018 1,483
HTS_TST_POS Service Delivery Point Agg Age (Facility) VCT: 15+, Male, Positive 2018 843
PMTCT_ART Already on ART at beginning of current pregnancy 2018 157
PMTCT_ART New on ART 2018 111
PMTCT_ART Number of HIV-positive pregnant women who received ART to reduce risk of mother-to-child-transmission (MTCT) during pregnancy 2018 268
PMTCT_ART Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 23,442
PMTCT_EID Number of infants who had a virologic HIV test within 12 months of birth during the reporting period 2018 204
PMTCT_EID Number of infants with a negative virological test result between 2 and 12 months of birth 2018 31
PMTCT_EID Number of infants with a negative virological test result within 2 months of birth 2018 173
PMTCT_STAT By Age (Numerator): : 15-19 2018 1,364
PMTCT_STAT By Age (Numerator): 20-24 2018 7,317
PMTCT_STAT By Age (Numerator): 25-49 2018 14,761
PMTCT_STAT By known positives: 15-19 2018 5
PMTCT_STAT By known positives: 20-24 2018 50
PMTCT_STAT By known positives: 25-49 2018 107
PMTCT_STAT By new negatives: 15-19 2018 1,356
PMTCT_STAT By new negatives: 20-24 2018 7,231
PMTCT_STAT By new negatives: 25-49 2018 14,579
PMTCT_STAT By new positives: 15-19 2018 3
PMTCT_STAT By new positives: 20-24 2018 36
PMTCT_STAT By new positives: 25-49 2018 75
PMTCT_STAT Number of pregnant women with known HIV status (includes women who were tested for HIV and received their results) 2018 23,442
PMTCT_STAT_den By Age (Denominator): 15-19 2018 1,444
PMTCT_STAT_den By Age (Denominator): 20-24 2018 7,700
PMTCT_STAT_den By Age (Denominator): 25-49 2018 15,520
TB_ART Aggregated Age/Sex: Female 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 150
TB_ART Aggregated Age/Sex: Male 15+ (Numerator: The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period) 2018 252
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period 2018 435
TB_ART The number of registered new and relapse TB cases with documented HIV-positive status who are on ART during TB treatment during the reporting period 2018 402
TB_ART_den Aggregated Age/Sex: Female 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 162
TB_ART_den Aggregated Age/Sex: Male 15+ (Denominator: The number of registered new and relapse TB cases with documented HIV-positive status during TB treatment during the reporting period) 2018 273
TB_STAT Aggregated Age/Sex: Female <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 34
TB_STAT Aggregated Age/Sex: Female 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,684
TB_STAT Aggregated Age/Sex: Male <15 (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 28
TB_STAT Aggregated Age/Sex: Male 15+ (Numerator: Number of registered new and relapsed TB cases with documented HIV status, during the reporting period) 2018 1,165
TB_STAT Number of registered new and relapsed TB cases with documented HIV status, during the reporting period 2018 2,911
TB_STAT Total number of registered new and relapsed TB cases, during the reporting period 2018 3,424
TB_STAT_den Aggregated Age/Sex: Female <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 37
TB_STAT_den Aggregated Age/Sex: Female 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,989
TB_STAT_den Aggregated Age/Sex: Male <15 (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 31
TB_STAT_den Aggregated Age/Sex: Male 15+ (Denominator: Total number of registered new and relapsed TB cases, during the reporting period) 2018 1,367
TX_CURR Aggregated Age/Sex: <15 Female 2018 315
TX_CURR Aggregated Age/Sex: <15 Male 2018 391
TX_CURR Aggregated Age/Sex: 15+ Female 2018 4,860
TX_CURR Aggregated Age/Sex: 15+ Male 2018 2,762
TX_CURR Number of adults and children receiving antiretroviral therapy (ART) 2018 8,328
TX_CURR Sum of Aggregated Age/Sex <15 2018 706
TX_CURR Sum of Aggregated Age/Sex 15+ 2018 7,622
TX_CURR Sum of Aggregated Age/Sex disaggregates 2018 8,328
TX_NEW Aggregated Grouping by Age/Sex: <15 Female 2018 37
TX_NEW Aggregated Grouping by Age/Sex: <15 Male 2018 58
TX_NEW Aggregated Grouping by Age/Sex: 15+ Female 2018 1,119
TX_NEW Aggregated Grouping by Age/Sex: 15+ Male 2018 669
TX_NEW Number of adults and children newly enrolled on antiretroviral therapy (ART) 2018 1,883
TX_NEW Pregnancy status 2018 110
TX_NEW Sum of Aggregated Age/Sex disaggregates 2018 1,883
TX_PVLS Number of adult and pediatric ART patients with a viral load result documented in the patient medical record and /or laboratory records in the past 12 months 2018 1,720
TX_PVLS Number of adults and pediatric patients on ART with suppressed viral load results (<1,000 copies/ml) documented in the medical records and /or supporting laboratory results within the past 12 months 2018 1,031
TX_PVLS Numerator: Indication: Routine 2018 1,031
TX_RET Number of adults and children who are still alive and on treatment at 12 months after initiating ART 2018 1,461
TX_RET Total number of adults and children who initiated ART in the 12 months prior to the beginning of the reporting period, including those who have died, those who have stopped ART, and those lost to follow-up 2018 1,720
Cross Cutting Budget Categories and Known Amounts Total: $75,000
Gender: Gender Equality $75,000
Changing harmful gender norms and promoting positive gender norms
Equity in HIV prevention, care, treatment and support